24 July 2024

💥We are delighted to announce that the O2L-001 technology developed by Op2Lysis to treat massive and deep cerebral haemorrhage 🩸🧠 has reached a new milestone. The first “Dose Range Finding” safety study has produced very positive results. This success means that highly effective doses can be used in clinical trials.